Trials / Enrolling By Invitation
Enrolling By InvitationNCT07258199
TACE Treats Nodular Goiter
Transarterial Chemoembolization With Bleomycin: A Promising Treatment of Giant Nodular Goiter
- Status
- Enrolling By Invitation
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Peking Union Medical College Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
transarterial bleomycin chemoembolization represents a novel minimally invasive therapeutic approach for the management of giant nodular goiter.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | TACE | TACE, 15,000U bleomycin and 200-400μm drug-loaded microspheres |
Timeline
- Start date
- 2025-09-01
- Primary completion
- 2026-09-01
- Completion
- 2027-09-01
- First posted
- 2025-12-02
- Last updated
- 2025-12-02
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07258199. Inclusion in this directory is not an endorsement.